Literature DB >> 19010266

New advances in high-technology radiotherapy for head and neck cancer.

Gregory J Kubicek1, Mitchell Machtay.   

Abstract

Radiotherapy has an integral role in the treatment of head and neck cancer. Although radiotherapy has the potential to cure patients with advanced disease it also carries the potential for significant long-term morbidity. New technologies in the setting of head and neck radiotherapy are emerging, which have the potential to increase the cure rate and decrease toxicity. These new technologies include improved radiotherapy treatment design (intensity modulated radiation therapy) and improved planning and implementation (image-guided radiation therapy). Some of these advances are discussed in this article.

Entities:  

Mesh:

Year:  2008        PMID: 19010266     DOI: 10.1016/j.hoc.2008.08.014

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

1.  Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy.

Authors:  G Sanguineti; F Ricchetti; O Thomas; B Wu; T McNutt
Journal:  Br J Radiol       Date:  2013-09-12       Impact factor: 3.039

2.  Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer.

Authors:  A Fiorentino; R Caivano; V Metallo; C Chiumento; M Cozzolino; G Califano; S Clemente; P Pedicini; V Fusco
Journal:  Br J Radiol       Date:  2012-05-09       Impact factor: 3.039

3.  Dosimetric comparison between VMAT plans using the fast-rotating O-ring linac with dual-layer stacked MLC and helical tomotherapy for nasopharyngeal carcinoma.

Authors:  Sang Gyu Ju; Yong Chan Ahn; Yeong-Bi Kim; Jin Man Kim; Dong Yeol Kwon; Byoung Suk Park; Kyungmi Yang
Journal:  Radiat Oncol       Date:  2022-09-12       Impact factor: 4.309

4.  Development of a Tongue Immobilization Device Using a 3D Printer for Intensity Modulated Radiation Therapy of Nasopharyngeal Cancer Patients.

Authors:  Sang Gyu Ju; Yong Chan Ahn; Yeong-Bi Kim; Seung Gyu Park; Yoo-Mi Choi; Cho Hee Na; Chae-Seon Hong; Dongryul Oh; Dong Yeol Kwon; Cheol Chong Kim; Dong Hyeon Kim
Journal:  Cancer Res Treat       Date:  2020-09-15       Impact factor: 4.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.